Uyl-de Groot C A, Rutten F F
Erasmus Universiteit, Instituut voor Medische Technology Assessment/Instituut voor Beleid en Management Gezondheidszorg, Rotterdam.
Ned Tijdschr Geneeskd. 1994 Jan 1;138(1):28-31.
To estimate the costs of an autologous bone marrow transplantation (auto BMT) for patients with non-Hodgkin lymphoma and patients with acute lymphoid leukaemia.
Cost analysis.
Five Dutch hospitals.
By means of detailed cost registration forms, interviews with haematologists, research nurses, research analysts and hospital information systems, the costs of auto BMT were estimated.
The costs of an auto BMT were estimated at f 63,400 per patient with non-Hodgkin lymphoma and at f 86,400 for patients with acute leukaemia. The latter patients stayed longer in hospital and needed more intensive isolation care, more blood transfusions and more antibiotics.
These data are important when the Medical Insurance Board decides on provision for this treatment.
